Researchers from UTMB have teamed up with three other universities and the U.S. Army to develop and test a broad-spectrum antiviral compound capable of stopping dangerous viruses including Ebola, HIV, hepatitis C, West Nile, Rift Valley fever and yellow fever. The study is published online in the Proceedings of the National Academy of Sciences. The findings are receiving widespread coverage and appear in R&D Magazine as well as the Galveston County Daily News.